BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15596705)

  • 1. Variable response to long-term corticosteroid therapy in chronic beryllium disease.
    Sood A; Beckett WS; Cullen MR
    Chest; 2004 Dec; 126(6):2000-7. PubMed ID: 15596705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term response to corticosteroid therapy in chronic beryllium disease.
    Marchand-Adam S; El Khatib A; Guillon F; Brauner MW; Lamberto C; Lepage V; Naccache JM; Valeyre D
    Eur Respir J; 2008 Sep; 32(3):687-93. PubMed ID: 18757698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhaled corticosteroids on lung function in chronic beryllium disease.
    Mroz MM; Ferguson JH; Faino AV; Mayer A; Strand M; Maier LA
    Respir Med; 2018 May; 138S():S14-S19. PubMed ID: 29453139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
    Newman LS; Kreiss K; King TE; Seay S; Campbell PA
    Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS; Hamzeh N; Maier LA
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.
    Inoue Y; Barker E; Daniloff E; Kohno N; Hiwada K; Newman LS
    Am J Respir Crit Care Med; 1997 Jul; 156(1):109-15. PubMed ID: 9230733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent chronic beryllium disease in residents surrounding a beryllium facility.
    Maier LA; Martyny JW; Liang J; Rossman MD
    Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS; Newman LS
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum angiotensin converting enzyme activity in chronic beryllium disease.
    Newman LS; Orton R; Kreiss K
    Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS; Mroz MM; Balkissoon R; Maier LA
    Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA; Kittle LA; Mroz MM; Newman LS
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
    Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
    Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
    Hasejima N; Kobayashi H; Takezawa S; Yamato K; Kadoyama C; Kawano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1105-10. PubMed ID: 8544383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pulmonary physiologic abnormalities in beryllium disease.
    Pappas GP; Newman LS
    Am Rev Respir Dis; 1993 Sep; 148(3):661-6. PubMed ID: 8368637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis.
    Li L; Silveira LJ; Hamzeh N; Gillespie M; Mroz PM; Mayer AS; Fingerlin TE; Maier LA
    Eur Respir J; 2016 Jun; 47(6):1797-808. PubMed ID: 27103383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease.
    Maier LA; Raynolds MV; Young DA; Barker EA; Newman LS
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1342-50. PubMed ID: 10194187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic beryllium disease among dental technicians in Israel.
    Fireman E; Kramer MR; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):215-21. PubMed ID: 18038921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis.
    Verma DK; Ritchie AC; Shaw ML
    Occup Med (Lond); 2003 May; 53(3):223-7. PubMed ID: 12724557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.